CytomX Therapeutics, Inc.
$812.63M- Market cap
- $808.41M
- Debt
- +$16.89M
- Cash
- −$12.67M
Capital structure 98% equity / 2% debt · EV / Revenue 10.66x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
CTMX · current priceP/S 10.61x
$3.71Latest market snapshot
Implied fair value · at CHPT's multiple
$0.3690.4% below market
0.55 CTMX revenue / share×0.65x CHPT P/S=$0.36
Market $3.71Implied $0.36
CHPT · current priceP/S 0.65x
$9.89Latest market snapshot
Implied fair value · at CTMX's multiple
$162.481,542.9% above market
15.32 CHPT revenue / share×10.61x CTMX P/S=$162.48
Market $9.89Implied $162.48